Blood Test Can Predict Prognosis in Deadly Brain Cancer Glioblastoma
A blood test that measures the amount of cell-free DNA (cfDNA) in the bloodstream — called a liquid biopsy — correlates with how patients will progress after they are diagnosed with glioblastoma (GBM). This is the deadliest and most common primary brain tumor in adults. In a new study, researchers from the Abramson Cancer Center ...